Original language | English |
---|---|
Pages (from-to) | 215-216 |
Number of pages | 2 |
Journal | Schizophrenia Research |
Volume | 189 |
DOIs | |
State | Published - Nov 2017 |
Externally published | Yes |
Bibliographical note
Funding Information:Y. Weinstein was partly supported by a Tauber Foundation grant.
Funding Information:
Weinstein, Roe and Gelkopf report no disclosure. Levine received no support for this study and in unrelated work author Levine has received research support, and/or consultancy fees and/or travel support from F. Hoffmann-La Roche, Shire Pharmaceuticals (45031) and Eli Lilly (8635).
Funding
Y. Weinstein was partly supported by a Tauber Foundation grant. Weinstein, Roe and Gelkopf report no disclosure. Levine received no support for this study and in unrelated work author Levine has received research support, and/or consultancy fees and/or travel support from F. Hoffmann-La Roche, Shire Pharmaceuticals (45031) and Eli Lilly (8635).
Funders | Funder number |
---|---|
Tauber Foundation | |
Eli Lilly and Company | 8635 |
F. Hoffmann-La Roche | |
Shire | 45031 |